KPF
TDACW

K2 Principal Fund’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

K2 Principal Fund’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Sell
101,034
-95,425
-49% -$95.8K 0.01% 358
2026
Q1 		$23.6K Sell
196,459
-49,230
-20% -$11.3K ﹤0.01% 434
2025
Q4 		$76.2K Sell
245,689
-50,000
-17% -$16.4K 0.01% 337
2025
Q3 		$85.8K Hold
295,689
– – 0.01% 279
2025
Q2 		$68K Hold
295,689
– – 0.01% 244
2025
Q1 		$41.4K Buy
+295,689
New +$52K 0.01% 278

Other funds holding TDACW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

K2 Principal Fund's TDACW Position: Q2 2026 in Review

K2 Principal Fund reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 49% in Q2 2026, selling an estimated $95.8K and leaving 101,034 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #358.

K2 Principal Fund first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • K2 Principal Fund held 101,034 shares of Translational Development Acquisition Corp Warrants worth $143K as of Q2 2026.
  • K2 Principal Fund sold 95,425 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $95.8K.
  • Translational Development Acquisition Corp Warrants made up 0.01% of K2 Principal Fund's portfolio in Q2 2026, its #358 holding.
  • K2 Principal Fund first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.